Page last updated: 2024-09-04

tariquidar and Skin Neoplasms

tariquidar has been researched along with Skin Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charlton, PA; Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, SJ; Mills, L; Norris, D; Prin, A; Sharma, S; Whitehouse, PA	1

Other Studies

1 other study(ies) available for tariquidar and Skin Neoplasms

Article	Year
Ex vivo reversal of chemoresistance by tariquidar (XR9576). Anti-cancer drugs, 2004, Volume: 15, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Quinolines; Skin Neoplasms; Tumor Cells, Cultured	2004

Article

Year

Ex vivo reversal of chemoresistance by tariquidar (XR9576).

Anti-cancer drugs, 2004, Volume: 15, Issue:9

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Quinolines; Skin Neoplasms; Tumor Cells, Cultured

2004